Ani Pharmaceuticals (ANIP) Construction in Progress (2012 - 2013)

Ani Pharmaceuticals (ANIP) posted Construction in Progress of $197948.0 for Q3 2013, up 12.29% sequentially from $176276.0 in Q2 2013.

Ani Pharmaceuticals (ANIP) Construction in Progress (2012 - 2013) Analysis & Trends

Ani Pharmaceuticals has reported Construction in Progress for 2 years, with the latest figure at $197948.0 in Q3 2013.

Quarterly Construction in Progress changed N/A year-over-year to $197948.0 in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $197948.0 (changed N/A YoY) and the FY2012 annual result came in at $208069.0, changed N/A from the prior year.
Construction in Progress climbed to $197948.0 in Q3 2013 per ANIP's latest filing, from $176276.0 in the prior quarter.
Over five years, Construction in Progress peaked at $208069.0 in Q4 2012 and troughed at $176276.0 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Construction in Progress (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn	-
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Ani Pharmaceuticals	1.63 Bn	1.27 Bn	165.89 Mn	-

Download Data